<?xml version="1.0"?>
<rss version="2.0">
<channel>
<title>Inbox Robot: Atrial Fibrillation News</title>
<link>http://www.inboxrobot.com/news/atrial-fibrillation</link><description>Constantly updated news and information about a variety of topics.</description><item>
<title>Texas Cardiac Arrhythmia Institute at St. David&apos;s Medical Center Selected to Conduct Clinical Trial</title>
<link>http://www.inboxrobot.com/news.php?fid=191977835</link>
<pubDate>8 Oct 2008 00:37 GMT</pubDate>
<description>
...  Conduct Clinical Trial for Device to Treat Atrial Fibrillation Texas Cardiac Arrhythmia Institute at St. David&apos;s  ...  lesion that blocks the pathway for the abnormal heart rhythm. The new study involves second generation software  ...
</description>
</item><item>
<title>Insight On Common Heart Rhythm Disorder</title>
<link>http://www.inboxrobot.com/news.php?fid=191976061</link>
<pubDate>8 Oct 2008 00:32 GMT</pubDate>
<description>
...  that predispose humans to a combination of heart disease symptoms, including sinus node dysfunction, atrial fibrillation and ventricular arrhythmias. &quot;We were fortunate in this study to assemble an amazing collaboration  ...
</description>
</item><item>
<title>Novel imaging approach may assist in predicting success of treatment for atrial fibrillation</title>
<link>http://www.inboxrobot.com/news.php?fid=191976022</link>
<pubDate>8 Oct 2008 00:32 GMT</pubDate>
<description>
...  assist in predicting success of treatment for atrial fibrillation University of Utah researchers have developed a  ...  Atrial fibrillation (AF) is an arrhythmia, or abnormal heart rhythm, that involves the heart&apos;s two upper chambers,  ...
</description>
</item><item>
<title>Texas Cardiac Arrhythmia Institute at St. David&apos;s Medical Center Selected to Conduct Clinical Trial for Device to Treat</title>
<link>http://www.inboxrobot.com/news.php?fid=191969019</link>
<pubDate>7 Oct 2008 23:05 GMT</pubDate>
<description>
...  Conduct Clinical Trial for Device to Treat Atrial Fibrillation AUSTIN, Texas, Oct. 7 /PRNewswire/ -- The  ...  lesion that blocks the pathway for the abnormal heart rhythm. The new study involves second generation software  ...
</description>
</item><item>
<title>Texas Cardiac Arrhythmia Institute at St. David&apos;s Medical Center Selected to Conduct Clinical Trial for Device to Treat Atrial Fibrillation</title>
<link>http://www.inboxrobot.com/news.php?fid=191968639</link>
<pubDate>7 Oct 2008 22:59 GMT</pubDate>
<description>
...  the nation in pioneering new treatments for atrial fibrillation,&quot; Dr. Rodney Horton, electrophysiologist, Texas Cardiac Arrhythmia,  ...  lesion that blocks the pathway for the abnormal heart rhythm. The new study involves second generation software  ...
</description>
</item><item>
<title>Holiday can put Heart at risk</title>
<link>http://www.inboxrobot.com/news.php?fid=191960104</link>
<pubDate>7 Oct 2008 21:57 GMT</pubDate>
<description>
...  extreme of anything like alcohol, excitement or anxiety after a gap can lead to atrial fibrillation or irregular blood flow in the heart chambers that ultimately leads to the formation  ...
</description>
</item><item>
<title>Study provides insight on a common heart rhythm disorder</title>
<link>http://www.inboxrobot.com/news.php?fid=191959852</link>
<pubDate>7 Oct 2008 21:57 GMT</pubDate>
<description>
... Study provides insight on a common heart rhythm disorder University of Iowa researchers and colleagues in  ...  heart disease symptoms, including sinus node dysfunction, atrial fibrillation and ventricular arrhythmias. &quot;We were fortunate in  ...
</description>
</item><item>
<title>Endosense Launches TOCCATA Clinical Study</title>
<link>http://www.inboxrobot.com/news.php?fid=191915001</link>
<pubDate>7 Oct 2008 16:55 GMT</pubDate>
<description>
...  impact safety and performance of the catheter ablation treatment of cardiac rhythm disorders, including atrial fibrillation (AF). AF is the most common cardiac rhythm disorder today, affecting more than six  ...
</description>
</item><item>
<title>Global Health Partner AB: New Treatment Options for Swedish Patients with Cardiac Fibrillation</title>
<link>http://www.inboxrobot.com/news.php?fid=191883028</link>
<pubDate>7 Oct 2008 14:56 GMT</pubDate>
<description>
...  150,000 Swedes today are suffering from an abnormal heart rhythm (arrhythmia). Through a unique partnership, Global Health  ...  great need for treatment among patients with atrial fibrillation which can lead to serious complications such  ...
</description>
</item><item>
<title>CryoCath Announces Filing and Mailing of Directors&apos; Circular Unanimously Recommending Acceptance of</title>
<link>http://www.inboxrobot.com/news.php?fid=191805876</link>
<pubDate>7 Oct 2008 03:26 GMT</pubDate>
<description>
...  flagship product, Arctic Front, is a minimally invasive cryo-balloon catheter designed specifically to treat Atrial Fibrillation, an emerging $2 billion market opportunity. Marketed in Europe and the subject of a  ...
</description>
</item><item>
<title>CryoCath Announces Filing and Mailing of Directors&apos; Circular Unanimously Recommending Acceptance of Offer from Medtronic</title>
<link>http://www.inboxrobot.com/news.php?fid=191804103</link>
<pubDate>7 Oct 2008 03:15 GMT</pubDate>
<description>
...  flagship product, Arctic Front, is a minimally invasive cryo-balloon catheter designed specifically to treat Atrial Fibrillation, an emerging $2 billion market opportunity. Marketed in Europe and the subject of a  ...
</description>
</item><item>
<title>AtriCure Announces Web Cast and Conference Call of Third Quarter 2008 Financial Results</title>
<link>http://www.inboxrobot.com/news.php?fid=191795284</link>
<pubDate>7 Oct 2008 02:15 GMT</pubDate>
<description>
...  to create lesions in cardiac tissue to block the abnormal electrical impulses that cause atrial fibrillation, or AF, a rapid, irregular quivering of the upper chambers of the heart. Additionally,  ...
</description>
</item><item>
<title>deCODE Receives Nasdaq Deficiency Notice Relating to Market Value</title>
<link>http://www.inboxrobot.com/news.php?fid=191718895</link>
<pubDate>6 Oct 2008 20:20 GMT</pubDate>
<description>
...  prevention of common diseases, including deCODE T2(TM) for type 2 diabetes; deCODE AF(TM) for atrial fibrillation and stroke; deCODE MI(TM) for heart attack; deCODE ProCa(TM) for prostate cancer; deCODE Glaucoma(TM)  ...
</description>
</item><item>
<title>Pfizer, Boehringer Ingelheim&apos;s Spiriva Offers No Advantage Over Inhaled Placebo For COPD</title>
<link>http://www.inboxrobot.com/news.php?fid=191658280</link>
<pubDate>6 Oct 2008 10:32 GMT</pubDate>
<description>
...  no impact on the rate of chest pain or angina, a heart arrhythmia called atrial fibrillation or pneumonia. FinancialWire is a fully independent, proprietary news wire service of Investrend Information  ...
</description>
</item><item>
<title>12:14pm Mixed findings for Pfizer drug</title>
<link>http://www.inboxrobot.com/news.php?fid=191644928</link>
<pubDate>6 Oct 2008 07:56 GMT</pubDate>
<description>
...  no impact on the rate of chest pain or angina, a heart arrhythmia called atrial fibrillation or pneumonia. The Uplift results show that Spiriva should not be prescribed in hopes  ...
</description>
</item></channel>
</rss>
